Company: SGBAF
Filing Date: 2025-05-08
Form Type: F-4/A
Source: 0001193125-25-115825
Chunk: 347

Company: SES S.A.
Filing Date: 2025-05-08
Form: F-4/A
Chunk 347
---
 |     |      |  87 |
| Current                                     |     |      | 649 |     |      | 860 |

Unbilled accrued revenue represents revenue recognized, but not billed, under long-term customer contracts. Billing will occur based on the terms of the contracts. The non-currentbalance represents entirely unbilled accrued revenue. Other receivables include EUR 87 million (2023: EUR 350 million) to be received as part of the C-bandrepurposing project (refer to Note 36). An amount of EUR 6 million (2023: EUR 12 million) was expensed in 2024 reflecting a decrease in the impairment of trade and other receivables. This amount is recorded in ‘Other operating expenses’ and includes a reversal of provision of EUR 33 million (2023: EUR 30 million) mainly related to cash collections in respect of trade receivable balances previously provisioned. As of December 31, 2024, trade and other receivables with a nominal amount of EUR 114 million (2023: EUR 114 million) were impaired. Movements in the provision for the impairment of trade and other receivables were as follows:

| € million                      |     | 2024 |     |   |     | 2023 |     |   |
| Balance as of January 1        |     |      | 114 |   |     |      | 114 |   |
| Increase in provision          |     |      |  39 |   |     |      |  42 |   |
| Reversals of provision         |     |      | (33 | ) |     |      | (30 | ) |
| Utilised                       |     |      | (10 | ) |     |      |  (5 | ) |
| Other movements                |     |      |   — |   |     |      |  (3 | ) |
| Impact of currency translation |     |      |   4 |   |     |      |  (4 | ) |
| Balance as of December 31      |     |      | 114 |   |     |      | 114 |   |

Note 21—Financial instruments Fair value estimation and hierarchy The Group uses the following hierarchy levels for determining the fair value of financial instruments by valuation technique: Level 1—Quoted prices in active markets for identical assets or liabilities; Level 2—Other techniques for which all inputs which have a significant effect on